nk3201 has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imaizumi, S; Miura, S; Saku, K; Uehara, Y; Yahiro, E | 1 |
| Doggrell, SA; Wanstall, JC | 1 |
2 review(s) available for nk3201 and Cardiovascular Diseases
| Article | Year |
|---|---|
Chymase inhibitors.
Topics: Acetamides; Animals; Atrial Fibrillation; Azetidines; Benzoates; Cardiovascular Diseases; Chymases; Heart Failure; Humans; Hypertension; Mast Cells; Oxazoles; Pyrimidines; Quinazolines; Sulfonamides | 2013 |
Will chymase inhibitors be the next major development for the treatment of cardiovascular disorders?
Topics: Acetamides; Animals; Azetidines; Benzoates; Cardiovascular Diseases; Chymases; Disease Models, Animal; Humans; Pyrimidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Tunica Intima | 2003 |